INS and type 2 diabetes mellitus: In type 2 diabetes, disrupted MAM interface or function has been mostly studied in the main insulin target tissues (i.e., liver and skeletal muscle) as well as in pancreatic beta cells [12, 49, 50, 65], but not in the heart.